1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TMSB15A CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA AC138969.4 CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA ELAVL1 CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA RP11-15H20.8 CTRPv2 pan-cancer AAC 0.19 7e-09
mRNA ZKSCAN2 CTRPv2 pan-cancer AAC 0.2 7e-09
mRNA ZNF266 CTRPv2 pan-cancer AAC 0.2 7e-09
mRNA HMGB2 CTRPv2 pan-cancer AAC 0.22 7e-09
mRNA SLC35E2 CTRPv2 pan-cancer AAC 0.19 7e-09
mRNA ELAVL3 CTRPv2 pan-cancer AAC 0.22 7e-09
mRNA AC003006.7 CTRPv2 pan-cancer AAC 0.19 7e-09
Download CSV